| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP Finance CFO | SVP Finance &CFO
2 companies
Landry Robert E is an EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 82 sells.
Estimated insider holdings value: $15.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2023 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sell | 223 | $844.00 | $188,212.00 | -0.7% | -5.0% | +41.3% | |
| Mar 28, 2023 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 1,190 | $823.20 | $979,604.75 | -0.2% | -5.2% | +16.8% | |
| Feb 6, 2023 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 1,491 | $776.80 | $1,158,203.66 | -0.3% | -3.7% | +20.1% | |
| Dec 2, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 610 | $756.66 | $461,563.68 | -0.7% | +0.3% | +6.3% | |
| Nov 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 482 | $758.06 | $365,386.44 | -0.2% | -3.1% | +4.1% | |
| Oct 17, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 358 | $739.50 | $264,741.00 | -1.2% | -1.1% | +13.7% | |
| Apr 11, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 2,188 | $734.78 | $1,607,689.10 | -0.4% | -14.9% | +13.5% | |
| Apr 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 316 | $695.81 | $219,875.20 | -0.5% | -14.9% | +18.3% | |
| Mar 29, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 2,683 | $687.90 | $1,845,630.36 | -0.6% | -13.7% | +17.3% | |
| Mar 21, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 300 | $693.00 | $207,900.00 | -1.0% | -15.2% | +9.6% |